{"id":188558,"date":"2020-12-01T16:54:41","date_gmt":"2020-12-01T16:54:41","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=188558"},"modified":"2020-12-01T16:54:41","modified_gmt":"2020-12-01T16:54:41","slug":"pfizer-si-biontech-solicita-autorizarea-vaccinului-de-combatere-a-coronavirusului-in-europa-in-cel-mai-bun-caz-distribuirea-dozelor-poate-incepe-pana-la-finalul-anului","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=188558","title":{"rendered":"Pfizer \u015fi BioNTech solicit\u0103 autorizarea vaccinului de combatere a coronavirusului \u00een Europa: \u00cen cel mai bun caz, distribuirea dozelor poate \u00eencepe p\u00e2n\u0103 la finalul anului"},"content":{"rendered":"<p>\nFirma german\u0103 de biotehnologie BioNTech \u015fi gigantul farmaceutic american Pfizer i-au cerut Agen\u0163iei Europene pentru Medicamente (EMA) s\u0103 le aprobe utilizarea \u00een caz de urgen\u0163\u0103 a vaccinului anti-COVID-19 pe care l-au anun\u0163at \u00een urm\u0103 cu trei s\u0103pt\u0103m\u00e2ni, scrie Euronews.<\/p>\n<p>\nCele dou\u0103 companii au depus recent o cerere de aprobare a vaccinului \u015fi la Agen\u0163ia pentru Alimente \u015fi Medicamente din Statele Unite, mi\u015fcare replicat\u0103 de firma de biotehnologie Moderna.<\/p>\n<p>\nAnun\u0163ul indic\u0103 faptul c\u0103 vaccinul dezvoltat de Pfizer ar putea deveni valabil \u00een Uniunea European\u0103 pentru grupurile vulnerabile p\u00e2n\u0103 la finalul anului dac\u0103 EMA decide \u00een scurt timp c\u0103 \u201ebeneficiile vaccinului dep\u0103\u015fesc riscurile\u201d.<\/p>\n<p>\nCandidatul propus de BioNTech prezint\u0103 o eficien\u0163\u0103 de peste 94% \u00een r\u00e2ndurile adul\u0163ilor trecu\u0163i de 65 de ani, adic\u0103 una dintre categoriile de v\u00e2rst\u0103 cu cele mai mari \u015fanse de a dezvolta o form\u0103 sever\u0103 a bolii COVID-19.<\/p>\n<p>\n\u201eVom continua s\u0103 lucr\u0103m cu agen\u0163iile de reglementare din toat\u0103 lumea pentru a porni distribuirea rapid\u0103 a vaccinului, contribuind astfel la eforturile colective de revenire la normalitate\u201d, spune Ugur \u015eahin, CEO \u015fi cofondator al BioNTech.<\/p>\n<p>\nCompania a declarat la \u00eenceputul lunii trecute c\u0103 vaccinul a fost testat cu ajutorul a 43.000 de voluntari, iar Uniunea European\u0103 \u015fi-a asigurat p\u00e2n\u0103 acum circa 300 de milioane de doze.<\/p>\n<p>\nTotu\u015fi, procesele de stocare pot \u00eent\u00e2mpina probleme, de vreme ce vaccinul dezvoltat de Pfizer \u015fi BioNTech trebuie depozitat la temperaturi de circa -70 de grade celsius.<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Firma german\u0103 de biotehnologie BioNTech \u015fi gigantul farmaceutic american Pfizer i-au cerut Agen\u0163iei Europene pentru Medicamente (EMA) s\u0103 le aprobe utilizarea \u00een caz de urgen\u0163\u0103 a vaccinului anti-COVID-19 pe care l-au anun\u0163at \u00een urm\u0103 cu trei s\u0103pt\u0103m\u00e2ni, scrie Euronews. Cele dou\u0103 companii au depus recent o cerere de aprobare a vaccinului \u015fi la Agen\u0163ia pentru [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[511],"tags":[33019,47175,438,10429,18654,14930],"class_list":["post-188558","post","type-post","status-publish","format-standard","hentry","category-afaceri","tag-autorizare","tag-biontech","tag-europa","tag-pfizer","tag-solicitare","tag-vaccin"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=188558"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/188558\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=188558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=188558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=188558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}